|
humans |
46 |
|
nasopharyngeal carcinoma |
33 |
|
adult |
31 |
|
dna methylation |
30 |
|
male |
30 |
|
animals |
28 |
|
female |
28 |
|
gastric cancer |
24 |
|
whole-exome sequencing |
24 |
|
middle aged |
21 |
|
base sequence |
20 |
|
gene expression regulation, neoplastic |
19 |
|
medical sciences |
19 |
|
aged |
17 |
|
promoter hypermethylation |
17 |
|
mice |
16 |
|
hong kong |
14 |
|
molecular sequence data |
14 |
|
cancer susceptibility genes |
13 |
|
cell transformation, neoplastic - genetics |
13 |
|
early-age onset |
13 |
|
ebv |
13 |
|
epigenetics |
13 |
|
gene expression |
13 |
|
gene expression profiling |
13 |
|
immunohistochemistry |
13 |
|
mst1r |
13 |
|
rhizopus microsporus |
13 |
|
species index: fungi |
13 |
|
aged, 80 and over |
12 |
|
apobec-mediated signature |
12 |
|
dna, neoplasm - genetics |
12 |
|
epstein-barr virus |
12 |
|
mutation |
12 |
|
nf-κb signaling |
12 |
|
oligonucleotide array sequence analysis |
12 |
|
somatic mutation landscape |
12 |
|
amino acid sequence |
11 |
|
esophageal squamous cell carcinoma (escc) |
11 |
|
genes, tumor suppressor |
11 |
|
lymphatic metastasis - genetics |
11 |
|
metastasis |
11 |
|
methylation |
11 |
|
nasopharyngeal carcinoma (npc) |
11 |
|
nidogen-2 (nid2) |
11 |
|
tumor cells, cultured |
11 |
|
tumor suppressor proteins - genetics - metabolism |
11 |
|
arhgap fusions |
10 |
|
biobank |
10 |
|
blotting, western |
10 |
|
drug screening |
10 |
|
ebv genome |
10 |
|
enzyme activation |
10 |
|
gene silencing |
10 |
|
heterogeneity |
10 |
|
microcell hybrid |
10 |
|
neoplasm proteins - genetics - metabolism |
10 |
|
organoid culture |
10 |
|
promoter regions, genetic |
10 |
|
rhoa mutations |
10 |
|
transcriptome sequencing |
10 |
|
vegf |
10 |
|
adam proteins - biosynthesis - genetics - metabolism |
9 |
|
adolescent |
9 |
|
arginine methylation |
9 |
|
cancer stemness |
9 |
|
carcinoma - genetics |
9 |
|
cell cycle |
9 |
|
cell cycle arrest |
9 |
|
cell line, tumor |
9 |
|
chromosome 6p |
9 |
|
chromosomes, human, pair 14 - genetics |
9 |
|
colorectal cancer |
9 |
|
cpg islands |
9 |
|
e-cadherin |
9 |
|
endothelial cells - cytology |
9 |
|
esophageal neoplasms - blood supply - enzymology - genetics |
9 |
|
genetic predisposition to disease |
9 |
|
hcc |
9 |
|
illumina humanmethylation450 |
9 |
|
loss of heterozygosity |
9 |
|
lymphatic metastasis |
9 |
|
methylome |
9 |
|
mice, inbred balb c |
9 |
|
microcell-mediated chromosome transfer |
9 |
|
mipol1 |
9 |
|
nasopharyngeal neoplasms - blood supply - enzymology - genetics |
9 |
|
nasopharyngeal neoplasms - genetics - metabolism - pathology |
9 |
|
rna, messenger - metabolism |
9 |
|
stomach neoplasms - genetics - metabolism |
9 |
|
thy1 |
9 |
|
tumor suppressor gene |
9 |
|
tumor-initiating cells |
9 |
|
adaptor proteins, signal transducing - physiology |
8 |
|
antiangiogenesis |
8 |
|
cadherins - genetics - metabolism |
8 |
|
chromosomes, human, pair 11 |
8 |
|
colonic neoplasms - genetics - metabolism - pathology |
8 |
|
cytokines - genetics - physiology |
8 |
|
neoplasm staging |
8 |
|
neovascularization, pathologic - genetics |
8 |
|
nf-kappa b - metabolism |
8 |
|
reverse transcriptase polymerase chain reaction - methods |
8 |
|
transcription regulator |
8 |
|
tumor suppressor |
8 |
|
alpha b-crystallin (cryab) |
7 |
|
alpha-crystallin b chain - physiology |
7 |
|
anti-angiogenic |
7 |
|
apoptosis |
7 |
|
asian continental ancestry group |
7 |
|
carcinoma, squamous cell - genetics - pathology - secondary |
7 |
|
child, preschool |
7 |
|
chiroptera - virology |
7 |
|
chromosome 11q |
7 |
|
common cold - genetics |
7 |
|
coronavirus 229e, human - genetics - physiology |
7 |
|
coronavirus infections - genetics |
7 |
|
dna mutational analysis |
7 |
|
fibulin-2 |
7 |
|
gastric adenocarcinoma |
7 |
|
genes, tumor suppressor - physiology |
7 |
|
genome, viral |
7 |
|
hong kong - epidemiology |
7 |
|
immunoenzyme techniques |
7 |
|
immunoglobulins - deficiency - genetics - physiology |
7 |
|
irradiation microcell-mediated chromosome transfer |
7 |
|
membrane proteins - deficiency - genetics - physiology |
7 |
|
mice, transgenic |
7 |
|
microarray |
7 |
|
nasopharyngeal neoplasms - genetics - pathology |
7 |
|
neoplasm invasiveness |
7 |
|
phylogeny |
7 |
|
prognosis |
7 |
|
proto-oncogene proteins - genetics |
7 |
|
reverse transcriptase polymerase chain reaction |
7 |
|
rna, neoplasm - metabolism |
7 |
|
sars virus - classification - genetics - isolation & purification |
7 |
|
sars virus - genetics - physiology |
7 |
|
sequence analysis, dna |
7 |
|
severe acute respiratory syndrome - genetics |
7 |
|
transfection |
7 |
|
treatment outcome |
7 |
|
tumor markers, biological - blood |
7 |
|
viral proteins - blood - genetics |
7 |
|
adam proteins - genetics |
6 |
|
adamts9 |
6 |
|
adenocarcinoma - genetics |
6 |
|
adenocarcinoma - genetics - metabolism - pathology |
6 |
|
adenoma - genetics - metabolism - pathology |
6 |
|
angiogenesis |
6 |
|
antigens, thy-1 - genetics - metabolism |
6 |
|
antigens, thy-1 - physiology |
6 |
|
antiinvasive |
6 |
|
blood pressure monitoring, ambulatory |
6 |
|
carcinoma - genetics - pathology |
6 |
|
carcinoma - genetics - secondary |
6 |
|
cell movement |
6 |
|
cell proliferation |
6 |
|
cell signaling |
6 |
|
cells, cultured |
6 |
|
china |
6 |
|
chromosome 11 |
6 |
|
chromosome 3, metastasis |
6 |
|
chromosomes, human, pair 3 |
6 |
|
colon carcinogenesis |
6 |
|
colorectal cancer genes |
6 |
|
cross-sectional studies |
6 |
|
disease progression |
6 |
|
dna damage repair pathway |
6 |
|
dna primers |
6 |
|
down-regulation |
6 |
|
early-onset colon cancer |
6 |
|
enzyme-linked immunosorbent assay |
6 |
|
epstein−barr virus |
6 |
|
esophageal squamous cell carcinoma |
6 |
|
extracellular matrix protein |
6 |
|
fatty acids |
6 |
|
gastroenterology |
6 |
|
gene expression regulation, neoplastic - physiology |
6 |
|
genes, cdc - physiology |
6 |
|
helicobacter infections - complications |
6 |
|
helicobacter pylori |
6 |
|
histone bivalent switch |
6 |
|
human leukocyte antigen |
6 |
|
hypertension |
6 |
|
in situ hybridization |
6 |
|
incidence |
6 |
|
inflammation |
6 |
|
lymph nodes - pathology |
6 |
|
macrophages - physiology |
6 |
|
mice, nude |
6 |
|
microbiota |
6 |
|
microsatellite repeats - genetics |
6 |
|
mlh1 |
6 |
|
molecular sequence numbers |
6 |
|
nasopharyngeal neoplasms - genetics |
6 |
|
nidogen-2 |
6 |
|
npc genetics |
6 |
|
oligo-microarray |
6 |
|
predictive value of tests |
6 |
|
prevalence |
6 |
|
promoter regions, genetic - genetics |
6 |
|
proto-oncogene proteins c-bcl-2 |
6 |
|
receptor-like protein tyrosine phosphatases, class 5 - genetics - physiology |
6 |
|
serum biomarker |
6 |
|
sex characteristics |
6 |
|
tetracycline-regulated gene expression |
6 |
|
tumor markers, biological - genetics - metabolism |
6 |
|
up-regulation |
6 |
|
adenocarcinoma - blood - diagnosis |
5 |
|
adenocarcinoma - diagnosis - genetics - mortality |
5 |
|
antimetabolites, antineoplastic - pharmacology |
5 |
|
antioncogenes. |
5 |
|
azacitidine - analogs & derivatives - pharmacology |
5 |
|
bioinformatics |
5 |
|
biopsy |
5 |
|
brain neoplasms - genetics - metabolism - pathology |
5 |
|
cadherins - blood |
5 |
|
cancer |
5 |
|
child |
5 |
|
chinese |
5 |
|
chromosome deletion |
5 |
|
codon - genetics |
5 |
|
colonic neoplasms - genetics - metabolism |
5 |
|
colorectal neoplasms - genetics |
5 |
|
cpg islands - genetics |
5 |
|
dna-binding proteins |
5 |
|
dna-binding proteins - metabolism |
5 |
|
down-regulation - drug effects |
5 |
|
drug therapy, combination |
5 |
|
endothelial growth factors - metabolism |
5 |
|
fluorescent antibody technique |
5 |
|
gene amplification |
5 |
|
gene expression regulation, neoplastic - drug effects |
5 |
|
hmlh1 |
5 |
|
hydroxamic acids - pharmacology |
5 |
|
intracellular signaling peptides and proteins |
5 |
|
li-cadherin |
5 |
|
liver neoplasms - diagnosis - etiology - genetics - surgery |
5 |
|
liver transplantation - adverse effects |
5 |
|
living donors |
5 |
|
lymphokines - metabolism |
5 |
|
lymphomas-- genetic aspects. |
5 |
|
microsatellite instability |
5 |
|
microsatellite repeats |
5 |
|
nasopharyngeal neoplasms - metabolism |
5 |
|
promoter methylation |
5 |
|
prospective studies |
5 |
|
protein synthesis inhibitors - pharmacology |
5 |
|
proteins - genetics |
5 |
|
rna, messenger - genetics |
5 |
|
rna, messenger - genetics - metabolism |
5 |
|
rt-pcr |
5 |
|
sarcoma - diagnosis - etiology - genetics - surgery |
5 |
|
stomach - pathology |
5 |
|
stomach neoplasms - blood - diagnosis |
5 |
|
stomach neoplasms - diagnosis - genetics - mortality |
5 |
|
stomach neoplasms - genetics |
5 |
|
tissue distribution |
5 |
|
transplantation, homologous - adverse effects |
5 |
|
tumor markers, biological - genetics |
5 |
|
tumor segregant |
5 |
|
tumour marker |
5 |
|
vascular endothelial growth factor a |
5 |
|
vascular endothelial growth factors |
5 |
|
1-phosphatidylinositol 3-kinase - genetics |
4 |
|
acp |
4 |
|
adaptor proteins, signal transducing |
4 |
|
adenocarcinoma |
4 |
|
adenocarcinoma - etiology - genetics - metabolism |
4 |
|
adenocarcinoma - genetics - metabolism |
4 |
|
adenocarcinoma - metabolism - pathology |
4 |
|
adp-ribosylation factors - metabolism |
4 |
|
aldehyde reductase - genetics - metabolism |
4 |
|
algorithms |
4 |
|
allelic imbalance |
4 |
|
alternative splicing |
4 |
|
anti-bacterial agents - pharmacology - therapeutic use |
4 |
|
anti-infective agents - pharmacology - therapeutic use |
4 |
|
anti-ulcer agents - pharmacology - therapeutic use |
4 |
|
antibodies, bispecific |
4 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
4 |
|
axons - enzymology - pathology |
4 |
|
azacitidine - analogs & derivatives - therapeutic use |
4 |
|
base pair mismatch |
4 |
|
bax |
4 |
|
bcl-2 |
4 |
|
bcl-2-associated x protein |
4 |
|
biomarkers |
4 |
|
biopsy - instrumentation - methods |
4 |
|
bismuth |
4 |
|
breath tests |
4 |
|
cadherins |
4 |
|
cancer stem cell markers |
4 |
|
carbon isotopes - diagnostic use |
4 |
|
carcinoembryonic antigen |
4 |
|
carcinoma |
4 |
|
carcinoma - genetics - pathology - virology |
4 |
|
carrier proteins |
4 |
|
carrier proteins - genetics - metabolism |
4 |
|
caspase 3 |
4 |
|
caspases - metabolism |
4 |
|
ccl |
4 |
|
cdx2 |
4 |
|
cell cycle - physiology |
4 |
|
cell division - drug effects |
4 |
|
cell growth processes - physiology |
4 |
|
cell line |
4 |
|
cell movement - genetics |
4 |
|
cell movement - physiology |
4 |
|
cervical vertebrae |
4 |
|
chemokine (c-c motif) ligand |
4 |
|
chemokines, cc - genetics - immunology |
4 |
|
chromosome 3 transfer |
4 |
|
ci |
4 |
|
clarithromycin - pharmacology - therapeutic use |
4 |
|
confidence interval |
4 |
|
dermatomyositis - etiology - therapy |
4 |
|
diabetic neuropathies - enzymology - genetics - physiopathology |
4 |
|
diagnosis |
4 |
|
disease models, animal |
4 |
|
dna damage |
4 |
|
dna microarray |
4 |
|
dna mismatch repair - genetics |
4 |
|
dna modification methylases - antagonists & inhibitors |
4 |
|
down-regulation - genetics |
4 |
|
doxycycline - pharmacology |
4 |
|
drug resistance |
4 |
|
drug synergism |
4 |
|
dyspepsia - pathology |
4 |
|
endoscopy, digestive system - instrumentation |
4 |
|
enzyme inhibitors - therapeutic use |
4 |
|
epigenesis, genetic |
4 |
|
epithelial cancer |
4 |
|
equipment reuse |
4 |
|
exome |
4 |
|
experimental design |
4 |
|
extracellular signal-regulated map kinases - antagonists & inhibitors - metabolism |
4 |
|
flow cytometry |
4 |
|
galactitol - metabolism |
4 |
|
galactosemias - enzymology - genetics - physiopathology |
4 |
|
ganciclovir |
4 |
|
gastric carcinoma |
4 |
|
gastric intestinal metaplasia |
4 |
|
gastric mucosa - physiology |
4 |
|
gastritis |
4 |
|
gene expression regulation, neoplastic - immunology |
4 |
|
genes, ras |
4 |
|
genes, ras - genetics |
4 |
|
genes, tumor suppressor - genetics |
4 |
|
glioblastoma - genetics - metabolism - pathology |
4 |
|
glioma |
4 |
|
glutathione - metabolism |
4 |
|
gpi-linked proteins |
4 |
|
hazard ratio |
4 |
|
helicobacter |
4 |
|
helicobacter infections - drug therapy - pathology |
4 |
|
helix-loop-helix motifs |
4 |
|
herpesviridae infections - complications |
4 |
|
herpesvirus 4, human - isolation & purification |
4 |
|
herpesvirus 4, human - pathogenicity |
4 |
|
histone deacetylase inhibitor |
4 |
|
histone deacetylase inhibitors |
4 |
|
histone modification |
4 |
|
homeodomain proteins - genetics - metabolism |
4 |
|
hong kong chinese |
4 |
|
hr |
4 |
|
hydroxamic acids - therapeutic use |
4 |
|
hyperglycemia - enzymology - genetics - physiopathology |
4 |
|
id4 |
4 |
|
ihc |
4 |
|
inhibitor of differentiation proteins |
4 |
|
intestinal metaplasia |
4 |
|
lymph node metastasis |
4 |
|
lytic cycle |
4 |
|
macrophage migration-inhibitory factor |
4 |
|
macrophage migration-inhibitory factors - blood |
4 |
|
map kinase signaling system |
4 |
|
matrix metalloproteinase |
4 |
|
membrane proteins - genetics - metabolism |
4 |
|
membrane transport proteins |
4 |
|
metagenomics |
4 |
|
metaplasia - metabolism |
4 |
|
metronidazole - pharmacology - therapeutic use |
4 |
|
microbiome |
4 |
|
mmp |
4 |
|
motor neuron disease - etiology - therapy |
4 |
|
mucosal immunity |
4 |
|
mutagenesis |
4 |
|
mutational signature |
4 |
|
muts homolog 2 protein |
4 |
|
myositis - etiology - therapy |
4 |
|
nasopharyngeal neoplasms - complications |
4 |
|
neoplasm proteins - genetics |
4 |
|
neoplasm proteins - metabolism |
4 |
|
neoplasm recurrence, local - complications - therapy |
4 |
|
nerve fibers, myelinated - enzymology - pathology |
4 |
|
nerve tissue proteins - biosynthesis - genetics - physiology |
4 |
|
nerve tissue proteins - genetics - metabolism |
4 |
|
neural conduction - genetics |
4 |
|
next generation sequencing |
4 |
|
npc |
4 |
|
nuclear proteins |
4 |
|
nuclear proteins - genetics |
4 |
|
omeprazole - pharmacology - therapeutic use |
4 |
|
oncology |
4 |
|
organ transplant |
4 |
|
organoid model |
4 |
|
oxidative stress - genetics |
4 |
|
paraneoplastic inflammatory myopathy |
4 |
|
paraneoplastic motor neuropathy |
4 |
|
paraneoplastic syndromes - etiology - therapy |
4 |
|
physiological wnt/β-catenin signaling |
4 |
|
polymerase chain reaction |
4 |
|
precancerous conditions - metabolism |
4 |
|
protein biosynthesis |
4 |
|
proto-oncogene proteins - metabolism |
4 |
|
proto-oncogene proteins b-raf - genetics |
4 |
|
ranitidine - analogs & derivatives |
4 |
|
ras proteins - genetics |
4 |
|
receptors, transforming growth factor beta - genetics |
4 |
|
reverse-transcription polymerase chain reaction |
4 |
|
rna, messenger - biosynthesis - genetics |
4 |
|
romidepsin |
4 |
|
schwann cells - cytology - enzymology |
4 |
|
self-renewal network |
4 |
|
sequence homology, amino acid |
4 |
|
smoking - adverse effects |
4 |
|
specimen handling - instrumentation - methods - nursing |
4 |
|
ssc |
4 |
|
standard saline citrate |
4 |
|
stemness transition |
4 |
|
stomach neoplasms - blood - diagnosis - mortality |
4 |
|
stomach neoplasms - etiology - genetics - metabolism |
4 |
|
stomach neoplasms - genetics - pathology |
4 |
|
stomach neoplasms - genetics - pathology - virology |
4 |
|
stomach neoplasms - metabolism - pathology |
4 |
|
stress, physiological - enzymology - genetics - physiopathology |
4 |
|
survival analysis |
4 |
|
t-lymphocytes - immunology |
4 |
|
tartrate-resistant acid phosphatase |
4 |
|
transcription factors - genetics |
4 |
|
transcription factors - metabolism |
4 |
|
transcription, genetic |
4 |
|
tumor marker |
4 |
|
tumor suppressor genes |
4 |
|
tumor suppressor proteins |
4 |
|
tumor virus infections - complications |
4 |
|
tβrii |
4 |
|
up-regulation - genetics |
4 |
|
urea - analysis |
4 |
|
adenocarcinoma - complications - microbiology |
3 |
|
adenocarcinoma - drug therapy - enzymology - pathology |
3 |
|
adenocarcinoma - enzymology - pathology |
3 |
|
adenocarcinoma - ethnology - genetics |
3 |
|
adenocarcinoma - genetics - pathology |
3 |
|
adenocarcinoma - metabolism |
3 |
|
adenoma |
3 |
|
adenoma - enzymology - pathology |
3 |
|
adenoma - etiology - pathology |
3 |
|
adenomatous polyposis coli - genetics - pathology |
3 |
|
age factors |
3 |
|
amoxicillin-potassium clavulanate combination - therapeutic use |
3 |
|
angiopoietin-1 |
3 |
|
angiopoietin-2 |
3 |
|
angiopoietins |
3 |
|
anti-infective agents - therapeutic use |
3 |
|
anti-obesity agents - adverse effects - pharmacokinetics - pharmacology |
3 |
|
anti-ulcer agents - therapeutic use |
3 |
|
antineoplastic combined chemotherapy protocols - administration & dosage - therapeutic use |
3 |
|
apoptosis - drug effects |
3 |
|
apoptosis - drug effects - physiology |
3 |
|
apoptotic cells |
3 |
|
ascaris lumbricoides - isolation & purification |
3 |
|
asian continental ancestry group - genetics |
3 |
|
astrocytoma - blood supply - genetics |
3 |
|
astrocytoma - blood supply - metabolism - pathology |
3 |
|
astrocytoma - metabolism - pathology |
3 |
|
autoimmunity |
3 |
|
bacterial artificial chromosome |
3 |
|
bar |
3 |
|
base pair mismatch - genetics |
3 |
|
bcl-6 |
3 |
|
bile - chemistry |
3 |
|
bile acids and salts - chemistry |
3 |
|
blotting, northern |
3 |
|
blotting, southern |
3 |
|
brain neoplasms - blood supply - genetics |
3 |
|
brain neoplasms - blood supply - metabolism - pathology |
3 |
|
brain neoplasms - drug therapy - pathology |
3 |
|
brain neoplasms - epidemiology - metabolism - pathology |
3 |
|
brain neoplasms - genetics - pathology |
3 |
|
brain neoplasms - metabolism - pathology |
3 |
|
cancer cell |
3 |
|
cancer neuroscience |
3 |
|
carcinoma - genetics - metabolism - pathology |
3 |
|
carcinoma - metabolism - pathology - virology |
3 |
|
carcinoma - metabolism - virology |
3 |
|
carcinoma - pathology - virology |
3 |
|
carcinoma, non-small-cell lung - blood supply - metabolism |
3 |
|
carcinoma, non-small-cell lung - metabolism |
3 |
|
carcinoma, non-small-cell lung - virology |
3 |
|
carcinoma, squamous cell - ethnology - pathology - virology |
3 |
|
carcinoma, squamous cell - metabolism - pathology - virology |
3 |
|
carcinoma, squamous cell - parasitology |
3 |
|
carcinoma, squamous cell - virology |
3 |
|
caspase 7 |
3 |
|
caspases |
3 |
|
cell cycle - drug effects |
3 |
|
cell cycle proteins - biosynthesis - genetics |
3 |
|
cell division |
3 |
|
cell transformation, neoplastic |
3 |
|
cell transformation, neoplastic - metabolism |
3 |
|
central nervous system neoplasms - chemistry - genetics - pathology |
3 |
|
cerebellar neoplasms - blood supply - genetics |
3 |
|
chemokine ccl2 - biosynthesis |
3 |
|
chemokine ccl2 - metabolism |
3 |
|
children |
3 |
|
china - epidemiology |
3 |
|
cholesterol |
3 |
|
cholesterol - metabolism |
3 |
|
choristoma-complications |
3 |
|
chromosomal instability |
3 |
|
chromosome aberrations |
3 |
|
chromosomes, human, pair 14 - genetics - metabolism |
3 |
|
chromosomes, human, pair 9 - genetics |
3 |
|
chronic disease |
3 |
|
clonality |
3 |
|
coculture |
3 |
|
colitis, ulcerative - etiology - pathology |
3 |
|
colon |
3 |
|
colon - metabolism - pathology |
3 |
|
colon carcinoma |
3 |
|
colonic neoplasms - enzymology - pathology |
3 |
|
colonic neoplasms - etiology - pathology |
3 |
|
colonic neoplasms - metabolism |
3 |
|
colorectal neoplasms - ethnology - genetics |
3 |
|
colorectal neoplasms - genetics - metabolism - pathology |
3 |
|
colorectal neoplasms - genetics - pathology |
3 |
|
colorectal neoplasms, hereditary nonpolyposis - genetics |
3 |
|
combigem |
3 |
|
combination therapy |
3 |
|
combinatorial genetics |
3 |
|
comparative genomic hybridization |
3 |
|
complementary dna |
3 |
|
crispr |
3 |
|
crispr screen |
3 |
|
cyclin-dependent kinase inhibitor p21 |
3 |
|
cyclin-dependent kinase inhibitor p27 |
3 |
|
cyclins - biosynthesis - genetics |
3 |
|
cyclosporine - therapeutic use |
3 |
|
cystadenoma, papillary - complications - metabolism - pathology |
3 |
|
cysteine endopeptidases - physiology |
3 |
|
cysteine proteinase inhibitors - pharmacology |
3 |
|
dendritic cells |
3 |
|
dexamethasone - administration & dosage |
3 |
|
dextran sulfate - toxicity |
3 |
|
diabetes-insipidus-etiology |
3 |
|
diploidy |
3 |
|
dna primers - chemistry |
3 |
|
dna repair |
3 |
|
dna repair - genetics |
3 |
|
dna, complementary - chemistry - isolation & purification - metabolism |
3 |
|
dna, satellite - genetics |
3 |
|
double-blind method |
3 |
|
ebna2 |
3 |
|
ebv proteins |
3 |
|
endothelial growth factors - biosynthesis |
3 |
|
endothelial growth factors - genetics - metabolism |
3 |
|
endothelial growth factors - genetics - physiology |
3 |
|
energy intake |
3 |
|
enteric neuron |
3 |
|
enzyme activation - drug effects |
3 |
|
enzyme inhibitors - adverse effects - pharmacokinetics - pharmacology |
3 |
|
ependymoma |
3 |
|
ependymoma - blood supply - metabolism - pathology |
3 |
|
epidemiology |
3 |
|
epididymal cystadenoma |
3 |
|
epididymis - pathology |
3 |
|
epithelial cells - metabolism |
3 |
|
epstein-barr virus infections - complications |
3 |
|
european continental ancestry group - genetics |
3 |
|
eye neoplasms - pathology - virology |
3 |
|
fatty acid |
3 |
|
flt-1 |
3 |
|
founder effect |
3 |
|
gallbladder - drug effects - physiology |
3 |
|
gene deletion |
3 |
|
genes, p53 |
3 |
|
genetic predisposition to disease - genetics |
3 |
|
germ cell tumour |
3 |
|
germ-line mutation |
3 |
|
germline mutation |
3 |
|
glioblastoma |
3 |
|
glioblastoma - genetics - pathology |
3 |
|
glioblastoma - metabolism - pathology |
3 |
|
glioma - chemistry - genetics - pathology |
3 |
|
glioma - metabolism - pathology |
3 |
|
haplotypes - genetics |
3 |
|
head and neck neoplasms - metabolism - virology |
3 |
|
helicobacter infections - complications - drug therapy - pathology |
3 |
|
helicobacter infections - complications - microbiology |
3 |
|
helicobacter pylori - isolation & purification |
3 |
|
helicobacter pylori - isolation and purification |
3 |
|
hemangioblastoma |
3 |
|
herpesviridae infections |
3 |
|
herpesviridae infections - complications - pathology |
3 |
|
herpesvirus 4, human |
3 |
|
herpesvirus 4, human - genetics |
3 |
|
herpesvirus 4, human - genetics - isolation & purification - metabolism |
3 |
|
herpesvirus 4, human - immunology - isolation & purification |
3 |
|
high-throughput screening |
3 |
|
hndrg2 |
3 |
|
hnpcc |
3 |
|
hnpcc syndrome |
3 |
|
hong kong - ethnology |
3 |
|
ikbb |
3 |
|
immunosuppressive agents - therapeutic use |
3 |
|
intercellular signaling peptides and proteins - metabolism |
3 |
|
interleukin-1beta - genetics |
3 |
|
intestinal mucosa - enzymology - pathology |
3 |
|
intracranial |
3 |
|
intragenic deletion |
3 |
|
jumonji domain-containing histone demethylases |
3 |
|
kdr |
3 |
|
lacrimal apparatus - pathology |
3 |
|
lacrimal apparatus diseases - pathology |
3 |
|
lacrimal sac |
3 |
|
lactones - adverse effects - pharmacokinetics - pharmacology |
3 |
|
large intestine |
3 |
|
leukemia, lymphoid - complications - drug therapy |
3 |
|
leukemia, myelogenous, chronic, bcr-abl positive - pathology |
3 |
|
leupeptins - pharmacology |
3 |
|
lipase - antagonists & inhibitors |
3 |
|
lipid metabolism |
3 |
|
lipids - analysis |
3 |
|
lmp-1 |
3 |
|
lung |
3 |
|
lung carcinoma |
3 |
|
lung neoplasms - blood supply - metabolism |
3 |
|
lung neoplasms - metabolism |
3 |
|
lung neoplasms - metabolism - pathology - virology |
3 |
|
lung neoplasms - virology |
3 |
|
lupus |
3 |
|
lymphoepithelial carcinoma |
3 |
|
lymphoepithelioma |
3 |
|
lymphoepithelioma-like carcinoma |
3 |
|
lymphoid tissue - pathology - virology |
3 |
|
lymphokines - biosynthesis |
3 |
|
lymphokines - genetics - metabolism |
3 |
|
lymphokines - genetics - physiology |
3 |
|
lymphoma - epidemiology - metabolism - pathology |
3 |
|
lymphoma, b-cell, marginal zone - complications - microbiology |
3 |
|
lysozyme |
3 |
|
macrophage |
3 |
|
macrophages - pathology |
3 |
|
membrane glycoproteins - biosynthesis |
3 |
|
metronidazole - therapeutic use |
3 |
|
microglia |
3 |
|
mismatch repair gene mutation |
3 |
|
mitoxantrone - administration & dosage |
3 |
|
monocyte chemoattractant protein- 1 |
3 |
|
monocyte chemoattractant protein-1 |
3 |
|
multienzyme complexes - antagonists & inhibitors - physiology |
3 |
|
multivariate analysis |
3 |
|
muramidase - biosynthesis - genetics |
3 |
|
mutation - genetics |
3 |
|
necrotic cells |
3 |
|
neoplasm proteins - biosynthesis |
3 |
|
neoplasms - enzymology - genetics |
3 |
|
neoplasms - epidemiology - genetics - pathology - virology |
3 |
|
neoplasms, second primary - genetics - pathology |
3 |
|
neoplastic syndromes, hereditary - genetics - pathology |
3 |
|
neovascularization, pathologic |
3 |
|
neovascularization, pathologic - etiology |
3 |
|
neovascularization, pathologic - metabolism |
3 |
|
nerve degeneration - etiology |
3 |
|
nf‐κb/akt/gsk‐3β signalling pathway |
3 |
|
non-small cell lung carcinoma |
3 |
|
nose neoplasms - metabolism - pathology - virology |
3 |
|
nucleic acid hybridization |
3 |
|
obesity - drug therapy - metabolism |
3 |
|
oligodendroglioma |
3 |
|
oligodendroglioma - blood supply - metabolism - pathology |
3 |
|
omeprazole - therapeutic use |
3 |
|
oncogene proteins - genetics |
3 |
|
oncogene proteins, viral - genetics |
3 |
|
organ specificity |
3 |
|
organoid |
3 |
|
osteolysis - pathology |
3 |
|
oxidoreductases, n-demethylating - genetics |
3 |
|
p53 |
3 |
|
p53 mutation |
3 |
|
paraffin embedding |
3 |
|
paranasal sinus neoplasms - metabolism - pathology - virology |
3 |
|
paraneoplastic polyneuropathy - etiology |
3 |
|
paresthesia - etiology |
3 |
|
parietal lobe |
3 |
|
pedigree |
3 |
|
pilocytic astrocytoma |
3 |
|
pineal gland |
3 |
|
pituitary-gland |
3 |
|
ploidies |
3 |
|
polymerase chain reaction - methods |
3 |
|
polymorphism, single-stranded conformational |
3 |
|
precancerous conditions - epidemiology - microbiology - pathology - prevention & control |
3 |
|
precancerous conditions - genetics - metabolism - pathology |
3 |
|
primary brain lymphoma |
3 |
|
proteasome endopeptidase complex |
3 |
|
proto-oncogene proteins |
3 |
|
proto-oncogene proteins - biosynthesis - genetics |
3 |
|
proto-oncogene proteins b-raf |
3 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
3 |
|
proto-oncogene proteins c-bcl-6 |
3 |
|
random allocation |
3 |
|
receptor protein-tyrosine kinases - biosynthesis |
3 |
|
receptor protein-tyrosine kinases - metabolism |
3 |
|
receptor tyrosine kinase tie2 |
3 |
|
receptor, epidermal growth factor - genetics |
3 |
|
receptors, growth factor - genetics - physiology |
3 |
|
receptors, growth factor - metabolism |
3 |
|
receptors, mitogen - genetics - physiology |
3 |
|
receptors, vascular endothelial growth factor |
3 |
|
reference values |
3 |
|
risk factors |
3 |
|
rna - analysis |
3 |
|
rna, messenger - analysis |
3 |
|
rna, messenger - biosynthesis |
3 |
|
rna, neoplasm - genetics - metabolism |
3 |
|
rna, viral - analysis |
3 |
|
rna, viral - metabolism |
3 |
|
salivary gland |
3 |
|
sella-turcica |
3 |
|
sequence deletion |
3 |
|
sinonasal carcinoma |
3 |
|
skull-neoplasms-complications |
3 |
|
spinal cord neoplasms - blood supply - genetics |
3 |
|
statistics, nonparametric |
3 |
|
stomach neoplasms - complications - microbiology |
3 |
|
stomach neoplasms - drug therapy - enzymology - pathology |
3 |
|
stomach neoplasms - epidemiology - microbiology - pathology - prevention & control |
3 |
|
stomach neoplasms - etiology |
3 |
|
stomach neoplasms - genetics - metabolism - pathology |
3 |
|
stomach neoplasms - metabolism - virology |
3 |
|
sural nerve - pathology |
3 |
|
syndrome |
3 |
|
t-lymphocytes - pathology |
3 |
|
t-lymphocytes - physiology |
3 |
|
temporal lobe |
3 |
|
teratoma |
3 |
|
teratoma - drug therapy - pathology |
3 |
|
testicular neoplasms - complications - metabolism - pathology |
3 |
|
tomography, x-ray computed |
3 |
|
tongue neoplasms - parasitology |
3 |
|
transcription factors |
3 |
|
trichinella spiralis - isolation & purification |
3 |
|
trichinellosis - complications |
3 |
|
tumor cells, cultured - metabolism - pathology |
3 |
|
tumor microenvironment |
3 |
|
tumor suppressor protein p53 - biosynthesis |
3 |
|
tumor suppressor protein p53 - biosynthesis - genetics |
3 |
|
tumor suppressor protein p53 - metabolism |
3 |
|
tumor virus infections |
3 |
|
tumor vulnerability |
3 |
|
tumour-associated macrophages |
3 |
|
turcot's syndrome |
3 |
|
u373 |
3 |
|
ubiquitin-proteasome |
3 |
|
ubiquitins - metabolism |
3 |
|
undifferentiated carcinoma |
3 |
|
up-regulation - drug effects |
3 |
|
urinary retention - etiology |
3 |
|
vascular endothelial growth factor |
3 |
|
vascular endothelial growth factor receptor-1 |
3 |
|
vascular endothelial growth factor splice variants |
3 |
|
vascular permeability factor |
3 |
|
vidarabine - administration & dosage - analogs & derivatives |
3 |
|
viral matrix proteins - genetics |
3 |
|
von hippel-lindau disease - complications - metabolism - pathology |
3 |
|
von hippel-lindau syndrome |
3 |
|
weight loss |
3 |
|
whole-exome sequencing (wes) |
3 |
|
[13c]-urea breath test |
2 |
|
a146 |
2 |
|
adaptor proteins, signal transducing - genetics - metabolism |
2 |
|
adenocarcinoma - drug therapy - genetics - pathology |
2 |
|
adenocarcinoma - pathology - virology |
2 |
|
adenoma - genetics |
2 |
|
alleles |
2 |
|
amplification |
2 |
|
anti-bacterial agents |
2 |
|
anti-bacterial agents - therapeutic use |
2 |
|
antigens, neoplasm - genetics |
2 |
|
array cgh |
2 |
|
asia - epidemiology |
2 |
|
asian continental ancestry group - statistics and numerical data |
2 |
|
bone morphogenetic proteins - metabolism |
2 |
|
caco-2 cells |
2 |
|
cancer organoids |
2 |
|
carbon isotopes - analysis - diagnostic use |
2 |
|
carcinoma, large cell - genetics |
2 |
|
carcinoma, squamous cell - pathology - radiography - virology |
2 |
|
carrier proteins - genetics |
2 |
|
caspase-3 inhibitor |
2 |
|
cell adhesion molecules - genetics |
2 |
|
chemotherapy |
2 |
|
choristoma - microbiology |
2 |
|
chromosomes, human, pair 19 |
2 |
|
cigarette smoke |
2 |
|
cluster analysis |
2 |
|
colon - metabolism |
2 |
|
colonic polyps - genetics |
2 |
|
colonic polyps - genetics - pathology |
2 |
|
colorectal |
2 |
|
colorectal carcinoma |
2 |
|
colorectal neoplasms - diagnosis - ethnology |
2 |
|
colorectal neoplasms - drug therapy - genetics - pathology |
2 |
|
colorectal neoplasms - epidemiology - genetics |
2 |
|
colorectal neoplasms - etiology - genetics |
2 |
|
colorectal neoplasms - genetics - metabolism |
2 |
|
colorectal neoplasms - pathology - virology |
2 |
|
colorectal neoplasms, hereditary nonpolyposis - ethnology - genetics |
2 |
|
colorectal neoplasms, hereditary nonpolyposis - genetics - pathology |
2 |
|
crypt maturation program |
2 |
|
cyclin e - genetics - metabolism |
2 |
|
cytochrome c |
2 |
|
cytochrome c group - metabolism |
2 |
|
cytoskeletal proteins |
2 |
|
demyelinating-diseases-chemically-induced |
2 |
|
dermatofibrosarcoma |
2 |
|
dermatofibrosarcoma protuberans |
2 |
|
diagnosis, differential |
2 |
|
disease models |
2 |
|
dna fragmentation |
2 |
|
dna mismatch repair |
2 |
|
dna modification methylases - genetics - metabolism |
2 |
|
dna ploidy |
2 |
|
dna repair enzymes - genetics - metabolism |
2 |
|
dna, neoplasm - analysis |
2 |
|
dna-binding proteins - genetics |
2 |
|
dose-response relationship, drug |
2 |
|
drug therapy, combination - therapeutic use |
2 |
|
ear |
2 |
|
ear, middle |
2 |
|
early-onset colorectal cancer |
2 |
|
eating |
2 |
|
emilin1 |
2 |
|
endometrial neoplasms - etiology - genetics |
2 |
|
endoscopy |
2 |
|
endoscopy, digestive system |
2 |
|
enhancer |
2 |
|
epigenetic editing |
2 |
|
epithelial cells - drug effects - enzymology - pathology |
2 |
|
exons |
2 |
|
exons - genetics |
2 |
|
expression profiling |
2 |
|
eye proteins - biosynthesis |
2 |
|
family |
2 |
|
fasting |
2 |
|
follow-up studies |
2 |
|
frameshift mutation |
2 |
|
gastric epithelial cells |
2 |
|
gastric mucosa |
2 |
|
gastric mucosa - chemistry |
2 |
|
gastric mucosa - drug effects - enzymology - pathology |
2 |
|
gastric mucosa - immunology - microbiology - pathology |
2 |
|
gastric mucosa - pathology |
2 |
|
gastritis - diagnosis - drug therapy - pathology |
2 |
|
gastritis - metabolism |
2 |
|
gastrointestinal neoplasms - genetics - pathology |
2 |
|
gene dosage |
2 |
|
gene expression regulation |
2 |
|
genes, apc |
2 |
|
gist |
2 |
|
gremlin |
2 |
|
group ii phospholipases a2 |
2 |
|
helicobacter infections - complications - drug therapy |
2 |
|
helicobacter infections - diagnosis |
2 |
|
helicobacter infections - diagnosis - drug therapy - pathology |
2 |
|
helicobacter infections - epidemiology |
2 |
|
helicobacter infections - immunology - microbiology |
2 |
|
helicobacter infections - metabolism |
2 |
|
herpesviridae infections - diagnosis |
2 |
|
hexanes-toxicity |
2 |
|
hong kong chinese population |
2 |
|
hyperplasia |
2 |
|
information theoretic approaches |
2 |
|
inheritance patterns - genetics |
2 |
|
intercellular signaling peptides and proteins - biosynthesis |
2 |
|
international agencies |
2 |
|
intestinal neoplasms - genetics |
2 |
|
intestinal polyps - diagnosis - ethnology |
2 |
|
intestines - metabolism |
2 |
|
kit |
2 |
|
kras |
2 |
|
l-lactate dehydrogenase - metabolism |
2 |
|
leukemia, myeloid, acute - genetics |
2 |
|
macrophage migration-inhibitory factors - genetics - metabolism |
2 |
|
macrophages - immunology |
2 |
|
mass screening - methods |
2 |
|
meckel diverticulum - microbiology |
2 |
|
meckel's diverticulum |
2 |
|
melanoma - genetics |
2 |
|
microarrays |
2 |
|
multiomics |
2 |
|
muscle proteins |
2 |
|
mutations |
2 |
|
muts homolog 2 protein - genetics |
2 |
|
myofibroblast |
2 |
|
neoplasm invasiveness - genetics - pathology |
2 |
|
nerve tissue proteins - biosynthesis |
2 |
|
nerve-degeneration-drug-effects |
2 |
|
netherlands |
2 |
|
non-fasting |
2 |
|
nuclear proteins - genetics - metabolism |
2 |
|
oncogene proteins - genetics - metabolism |
2 |
|
oncogenes |
2 |
|
open reading frames - genetics |
2 |
|
organoids |
2 |
|
p53 mutations |
2 |
|
pan-cancer studies |
2 |
|
pdgfd |
2 |
|
pdgfra |
2 |
|
peptic ulcer - diagnosis - drug therapy - pathology |
2 |
|
phenotype |
2 |
|
phospholipases a - biosynthesis - genetics |
2 |
|
phosphoproteins - genetics |
2 |
|
point mutation - genetics |
2 |
|
precursor cell lymphoblastic leukemia-lymphoma - genetics |
2 |
|
printing- |
2 |
|
protein kinase c - genetics |
2 |
|
protein profiling |
2 |
|
proto-oncogene proteins - genetics - metabolism |
2 |
|
proto-oncogene proteins b-raf - genetics - metabolism |
2 |
|
proto-oncogene proteins c-kit |
2 |
|
proto-oncogene proteins c-raf - genetics |
2 |
|
pyloric antrum - pathology |
2 |
|
rapid urease test |
2 |
|
ras proteins - genetics - metabolism |
2 |
|
reagent strips |
2 |
|
receptor, ephb2 - biosynthesis - genetics |
2 |
|
receptor, platelet-derived growth factor alpha - genetics |
2 |
|
receptors, notch - metabolism |
2 |
|
reproducibility of results |
2 |
|
rhob |
2 |
|
selection strategies |
2 |
|
sensitivity and specificity |
2 |
|
sequence deletion - genetics |
2 |
|
signal transduction |
2 |
|
smoke - adverse effects |
2 |
|
stem cells - metabolism |
2 |
|
stomach |
2 |
|
stomach diseases - microbiology |
2 |
|
stomach neoplasms |
2 |
|
stomach neoplasms - pathology - virology |
2 |
|
stomach ulcer - drug therapy - microbiology - pathology |
2 |
|
stromal cells - pathology |
2 |
|
survival rate |
2 |
|
test meal |
2 |
|
time factors |
2 |
|
tobacco - adverse effects - chemistry |
2 |
|
tp53 |
2 |
|
transactivational ability |
2 |
|
trex2 |
2 |
|
tumor biomarkers |
2 |
|
tumor suppressor protein p53 - genetics |
2 |
|
tumor virus infections - diagnosis |
2 |
|
two-dimensional gel electrophoresis |
2 |
|
united states |
2 |
|
urea - analysis - diagnostic use |
2 |
|
urease - analysis |
2 |
|
urease reagent strip |
2 |
|
wnt proteins - genetics - metabolism |
2 |
|
2-repeat allele |
1 |
|
3t3 cells |
1 |
|
7-repeat allele |
1 |
|
adenocarcinoma - enzymology - genetics |
1 |
|
adenocarcinoma, mucinous - genetics - metabolism - pathology |
1 |
|
adenoma - genetics - pathology |
1 |
|
adhd |
1 |
|
adrenal cortex hormones - therapeutic use |
1 |
|
aging |
1 |
|
aneuploidy |
1 |
|
aneurysm, dissecting - pathology |
1 |
|
array-comparative genomic hybridization |
1 |
|
arteriosclerosis - complications - epidemiology - pathology |
1 |
|
atherosclerosis |
1 |
|
attention deficit disorder with hyperactivity - genetics |
1 |
|
autonomic neuropathy |
1 |
|
autopsy |
1 |
|
basal ganglia - pathology |
1 |
|
bmp |
1 |
|
brain - drug effects - pathology - physiopathology |
1 |
|
brain diseases - chemically induced - pathology - physiopathology |
1 |
|
brain diseases - pathology - radiography - surgery |
1 |
|
brain edema - etiology |
1 |
|
brain ischemia - diagnosis - pathology |
1 |
|
brain neoplasms - complications - diagnosis - pathology |
1 |
|
brain neoplasms - diagnosis - pathology |
1 |
|
brain neoplasms - diagnosis - surgery |
1 |
